Alpha-1 Antitrypsin Deficiency: Are You Overlooking a Leading Genetic Culprit in Liver Disease?

This education program offers expert guidance on alpha-1 antitrypsin deficiency (AATD)–associated liver disease (LD), aiming to enhance HCPs’ knowledge in diagnosing and assessing AATD-LD. It targets hepatologists, gastroenterologists, and pulmonologists, with a secondary focus on primary care providers, nurse practitioners, physician associates, and pediatricians managing patients with AATD.

Share

Program Content

Activities

Screening for AATD-LD
Screening for Alpha-1 Antitrypsin Deficiency Liver Disease: Call to Action
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 28, 2024

Expires: August 27, 2025

FAQs for AATD-LD
Alpha-1 Antitrypsin Deficiency in Liver Disease: Frequently Asked Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 10, 2024

Expires: December 09, 2025

Activities

Overlooking AATD in Liver Disease
Alpha-1 Antitrypsin Deficiency: Are You Overlooking a Leading Genetic Culprit in Liver Disease?
Video
Congratulations: You achieved a completion on 04/09/2022

Released: February 04, 2025

Expires: February 03, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Takeda Development Center Americas, Inc.

Takeda Development Center Americas, Inc.